RE:HME news article: Good or Bad for Quipt....Hmmmmmmmm"Rotech generated about $750 million of revenue and an EBITDA margin of nearly 30% in 2023."
"the net purchase price is about $1.32 billion, representing 6.3x multiple of LTM EBITDA, excluding synergies."
old Rotech prospectus shows:
- 2020 revenues of $503.2M,
- ebitda of $152.6M and
- ebitda-less-patient-capex of $99.3M
- ebitda margin of 30.3%
- ebitda-less-patient-capex margin of 19.7%
Purchase price is 6.3 x ebitda, so ~ 9.7 x ebitda-less-patient-capex